Invokana Use Linked to Development of Ketoacidosis
In May of 2015, the Food and Drug Administration issued warnings regarding the Type 2 diabetes medication Invokana and its link to diabetic ketoacidosis. This condition can be very serious leading to high levels of ketones in the body. There are numerous cases already filed against the manufacturers of Invokana due to the development of ketoacidosis which resulted in some needing hospitalization.
The FDA required SGLT2 inhibitor manufacturers provide updates regarding their labeling to include the warnings of ketoacidosis and urinary tract infections.
When an individual takes Invokana, the kidneys release the excess blood glucose through urination. This is supposed to help with Type 2 diabetes, but in the first year of its release, there were over 450 adverse effects reported. These include reports of kidney failure, dehydration, urinary tract infections, abnormal weight loss, and kidney stones. There are some individuals who had allergic reactions to the drug as well with tongue, face, lips, and throat swelling, as well as skin irritation.
Some of the lawsuits against the makers of Invokana claim that the manufacturer were negligent in their production and testing, or that they failed to warn users of the potential dangers.
If you or someone you know took Invokana and experienced side effects, you may have a right to file a claim against the manufacturer. This lawsuit can help you recover compensation for the damages you may have incurred as a result of a condition you developed.
At Bailey Peavy Bailey Cowan Heckaman, our team of dangerous drug attorneys is dedicated to protecting those who have been affected by defective drugs. If you have suffered harm, we want to help you hold the manufacturer accountable for their actions. Call us today and learn if you have a claim, as well as what our firm can do to help you move forward without financial concern. We’re here to stand by your side every step of the way.